"The Company has announced data from its Phase 2 clinical study and is moving forward with its clinical
program with a Phase 2 FDA meeting. A Phase 2 patient study in atopic dermatitis is on target to
complete enrolment in 4Q CY2019 with data in 1Q 2020"
Still unsure as to when the FDA meeting will occur, what it will entail, whether they'll state FDA approval etc ...
Any one?
"The Company has announced data from its Phase 2 clinical study...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.8¢ |
Change
0.003(0.77%) |
Mkt cap ! $592.7M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.5¢ | $1.079M | 3.290M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 940023 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 309188 | 10 |
View Market Depth
| Last trade - 14.22pm 11/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |